InsidersTradesSigma
Discover the complete record of transactions filed by Senderowicz Adrian, Director. Director active across 1 companies, notably Puma Biotechnology, INC.. Aggregated, 6 reports have been recorded. Total volume traded: €822k. The latest transaction was disclosed on 16 June 2022 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
6 of 6 declarations
Adrian Senderowicz is a Board Member at Puma Biotechnology, Inc. He plays a vital role in the governance of the company, bringing his expertise in biopharmaceuticals and drug development. His involvement on the board contributes to Puma Biotechnology's strategic direction.